The five-floor, 169,000-square-foot complex will be home to a host of leading researchers, including at least six Canada Research Chairs and Ontario distinguished researchers in biotechnology, green chemistry, plant pathology, and science and health. Research will include work on diabetes, cancer, infectious diseases, tropical diseases, West Nile virus and malaria.
Its major assets include a synthetic chemistry laboratory, a Containment Level 3 (CL3) laboratory, greenhouse, photophysical sciences laboratory, child and youth studies laboratory space, the Niagara campus of the Michael G. DeGroote School of Medicine, and a business incubator to develop new enterprises based on knowledge and innovations developed by Cairns researchers.
The project is named for the family of Roy Cairns, who contributed a $10-million impact gift to help complete the facility. The project has also received $38 million from the federal government’s Knowledge Infrastructure Program; $33.5 million from the government of Ontario and $2 million from the Niagara Region.